79 related articles for article (PubMed ID: 23732093)
1. [Medical perspectives of metabolomics: the example of renal carcinoma].
Dormoy V; Massfelder T
Med Sci (Paris); 2013 May; 29(5):463-8. PubMed ID: 23732093
[No Abstract] [Full Text] [Related]
2. [A case of renal cell carcinoma of horseshoe kidney that produced AFP and caused hypercalcemia].
Okada H; Kawabata G; Kamidono S; Ishigami J; Nakatsuka E
Hinyokika Kiyo; 1984 Oct; 30(10):1453-8. PubMed ID: 6084418
[TBL] [Abstract][Full Text] [Related]
3. [Heterogeneity of human renal cell carcinoma. III. 1 alpha,25-dihydroxyvitamin D3 receptor and inhibition on the growth of renal carcinoma cell lines].
Nagakura K
Nihon Hinyokika Gakkai Zasshi; 1986 Jan; 77(1):92-7. PubMed ID: 3014194
[No Abstract] [Full Text] [Related]
4. Norepinephrine producing renal cell carcinoma.
Koh CJ; Bochner BH; Stein JP; Fedenko AN; Dequattro V; Skinner DG
J Urol; 2001 Aug; 166(2):603. PubMed ID: 11458078
[No Abstract] [Full Text] [Related]
5. Expression of vascular endothelial growth factor protein in human renal cell carcinoma.
Turner K
BJU Int; 2004 Sep; 94(4):678. PubMed ID: 15329141
[No Abstract] [Full Text] [Related]
6. Editorial comment on: Expression of aquaporin 1 in primary renal tumors: a prognostic indicator of clear-cell renal cell carcinoma.
Rentsch CA; Bachmann A
Eur Urol; 2009 Oct; 56(4):699. PubMed ID: 18930584
[No Abstract] [Full Text] [Related]
7. Interleukin-6 produced by renal-cell carcinoma cells and progression of multiple myeloma.
Sakai A; Kawano M; Kuramoto A
N Engl J Med; 1991 Jun; 324(26):1893-4. PubMed ID: 2041555
[No Abstract] [Full Text] [Related]
8. Diffuse expression of MUC 1 in metastases of renal clear cell carcinoma as a possible therapeutic target for renal cancer.
Leroy X; Aubert S; Ballereau C; Birembaut P; Porchet N; Gosselin B; Copin MC
Histopathology; 2005 Oct; 47(4):435-6. PubMed ID: 16178902
[No Abstract] [Full Text] [Related]
9. Profilin 1 overexpression in renal cell carcinoma.
Minamida S; Iwamura M; Kodera Y; Kawashima Y; Ikeda M; Okusa H; Fujita T; Maeda T; Baba S
Int J Urol; 2011 Jan; 18(1):63-71. PubMed ID: 21091798
[TBL] [Abstract][Full Text] [Related]
10. Expression of Fas/APO-1 in renal cell carcinoma GRC-1 cell line during cell cycles.
Li H; Yu L; Guo Y; Liang Y; Wang D
Chin Med J (Engl); 1999 Nov; 112(11):1008-12. PubMed ID: 11721461
[No Abstract] [Full Text] [Related]
11. Involvement of bone morphogenetic protein 2 in ossification of renal cell carcinoma.
Yamasaki M; Nomura T; Mimata H; Nomura Y
J Urol; 2004 Aug; 172(2):475-6. PubMed ID: 15247706
[No Abstract] [Full Text] [Related]
12. Biological aspects of renal cell carcinoma.
Vugrin D
Semin Nephrol; 1987 Jun; 7(2):117-22. PubMed ID: 3306860
[No Abstract] [Full Text] [Related]
13. The proteins ARVCF and p0071 in renal cell carcinomas and their potential use in the diagnosis of renal tumours.
Walter B; Berger I; Hofmann I
Histopathology; 2009 Dec; 55(6):761-4. PubMed ID: 20002775
[No Abstract] [Full Text] [Related]
14. [Study of the expression of Aurora kinases in renal cell carcinoma].
Mathieu R; Patard JJ; Stock N; Rioux-Leclercq N; Guillé F; Fergelot P; Bensalah K
Prog Urol; 2010 Dec; 20(13):1200-5. PubMed ID: 21130399
[TBL] [Abstract][Full Text] [Related]
15. Expression and mutational analyses of KIT and PDGFR-alpha in sarcomatoid renal cell carcinoma.
Petit A; Castillo M; Gaspa A; Colomer D; Garcia de Albéniz X; Moreno C; Camós M; Mellado B; Mallofré C
Histopathology; 2009 Aug; 55(2):230-2. PubMed ID: 19694830
[No Abstract] [Full Text] [Related]
16. MUC1 immunoexpression is a virtually constant feature of clear cell renal cell carcinoma metastatic to the pancreas.
Pająk J; Liszka L; Mrowiec S; Gołka D; Lampe P
Adv Anat Pathol; 2012 Mar; 19(2):125-7. PubMed ID: 22313840
[No Abstract] [Full Text] [Related]
17. [Glycolipid alterations in human kidney carcinoma].
Sakakibara N
Hokkaido Igaku Zasshi; 1989 Jan; 64(1):75-82. PubMed ID: 2542145
[TBL] [Abstract][Full Text] [Related]
18. In search of a better crystal ball: recent advances in prognostic markers for clear-cell renal cell carcinoma.
Shah JB; Margulis V
Expert Rev Anticancer Ther; 2010 Jun; 10(6):837-42. PubMed ID: 20553209
[TBL] [Abstract][Full Text] [Related]
19. [Histochemical characteristics of renal cell cancer].
Shliapnikov VV
Arkh Patol; 1986; 48(12):53-7. PubMed ID: 3566548
[TBL] [Abstract][Full Text] [Related]
20. Beta2 microglobulin: a surprising therapeutic target for prostate cancer and renal cell carcinoma.
Freeman MR
J Urol; 2007 Jul; 178(1):10-1. PubMed ID: 17574050
[No Abstract] [Full Text] [Related]
[Next] [New Search]
